3Kulke M, Bergsland E, Ryan DP, et al. A phase Ⅱ, open-label,safety, pharmacokinetic, and efficacy study of recombinant human endostatin in patients with advanced neuroendocrine tumors. Proc Am Soc Clin Oncol, 2003, 22: 239.
4Fossella FV. Docetaxel in second-line treatment of non-small-cell lung cancer. Clin Lung Cancer, 2002, 3 (Suppl 2) :S23-28.